Greaves Cotton recovers, up by 2 per cent
Greaves Cotton recovers, up by 2 per cent

Greaves Cotton recovers, up by 2 per cent

DSIJ Intelligence Article rating: 4.0

Greaves Cotton has acquired 25,73,529 equity shares of its subsidiary Ampere Vehicles by way of investment through primary and secondary purchase for a total consideration of Rs. 38.49 crore.

Index trend and stocks in action July 16, 2019
Index trend and stocks in action July 16, 2019

Index trend and stocks in action July 16, 2019

DSIJ Intelligence-3 Article rating: 5.0

Nifty needs to convincingly hold above 11,600-11,650 to provide fresh impetus to the bulls. On the downside, the level of 11,426-11,461 is likely to act as a support for the index. Stocks in news: SBI, NTPC, Ashok Leyland, Greaves Cotton, Capacite Infraprojects, Aditya Birla Fashion.

DHFL hits 52 week low
DHFL hits 52 week low

DHFL hits 52 week low

Nidhi Jani Article rating: 5.0

The company in its exchange filing said that due to sharp slowdown in disbursement and loan growth post September 2018, the financials of the company have been quite strained for the quarter impacting the overall performance of the year.

JB Chemicals enters MoU with Greenscape Builders
JB Chemicals enters MoU with Greenscape Builders

JB Chemicals enters MoU with Greenscape Builders

DSIJ Intelligence Article rating: 5.0

JB Chemicals & Pharmaceuticals has entered into a Memorandum of Understanding (MoU) with Greenscape Builders & Developers. Shares of the company however closed on a negative note.


GSPL gives trendline breakout
GSPL gives trendline breakout

GSPL gives trendline breakout

Vinayak Gangule Article rating: 5.0

The stock of Gujarat State Petronet Limited (GSPL) has given downward sloping trendline breakout on the daily scale formed by connecting swing highs from August 8, 2018.

Natco Pharma: USFDA inspection ends with no observations
Natco Pharma: USFDA inspection ends with no observations

Natco Pharma: USFDA inspection ends with no observations

DSIJ Intelligence Article rating: 5.0

US Food and Drug Administration (USFDA) has completed the inspection at Natco Pharma’s Chennai unit. The shares of the company rose almost 2 per cent on the back of the news in the early trade but failed to sustain the gains and fell in the afternoon session.


RSS
First32343235323632373239324132423243Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR